Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage.
Abdalla A AmmarMahmoud A AmmarKent A OwusuStacy C BrownFiras KaddouhAladine A ElsamadicyJulián N AcostaGuido J FalconePublished in: Neurocritical care (2021)
In this limited sample of patients, we found no difference in neuroimaging stability, functional outcome and thrombotic events when comparing AA and 4F-PCC in patients with FXi-related ICH. Since our analysis is likely underpowered, a multi-center collaborative network devoted to this question is warranted.